Product Information
MEXILETINE 150 MG CAPSULE is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2387 per EA under NDC 50742023901. Its NADAC has been published 265 times since Jun 2, 2021.
Strength
150 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742023901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214352On Market Since
1/26/2021
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 150 MG CAPSULE has been published 265 times since Jun 2, 2021, and over the history we have for it it has declined 69.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2387 per EA |
|---|---|
| All-time high | $0.8263 (Jan 12, 2022) |
| All-time low | $0.2193 (Jul 17, 2024) |
| 52-week high | $0.2727 |
| 52-week low | $0.2387 |
| Median price | $0.3701 |
| Average price | $0.4189 |
| Largest weekly change | -34.2% (Apr 17, 2024) |
| Weeks tracked | 265 |
| Tracking since | Jun 2, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 150 MG CAPSULE, manufactured by Ingenus Pharmaceuticals LLC, is $0.2387 per EA (NDC 50742023901), effective Jun 24, 2026.
How has the price of MEXILETINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 150 MG CAPSULE has declined 69.4%. It has been tracked across 265 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for MEXILETINE 150 MG CAPSULE?
Since Jun 2, 2021, the NADAC for MEXILETINE 150 MG CAPSULE has ranged from a low of $0.2193 (Jul 17, 2024) to a high of $0.8263 (Jan 12, 2022), with a median of $0.3701 per EA.
Are there cheaper alternatives to MEXILETINE 150 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MEXILETINE 150 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 150 MG CAPSULE?
MEXILETINE 150 MG CAPSULE (NDC 50742023901) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification